Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study

INTRODUCTION: Pneumococcal conjugate vaccines (PCVs) prevent disease through both direct protection of vaccinated individuals and indirect protection of unvaccinated individuals by reducing nasopharyngeal (NP) carriage and transmission of vaccine-type (VT) pneumococci. While the indirect effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Jocelyn, Nguyen, Cattram D, Lai, Jana Y R, Dunne, Eileen M, Andrews, Ross, Blyth, Christopher C, Datta, Siddhartha, Fox, Kim, Ford, Rebecca, Hinds, Jason, La Vincente, Sophie, Lehmann, Deborah, Lim, Ruth, Mungun, Tuya, Newton, Paul N, Phetsouvanh, Rattanaphone, Pomat, Willam S, Xeuatvongsa, Anonh, von Mollendorf, Claire, Dance, David A B, Satzke, Catherine, Muholland, Kim, Russell, Fiona M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961565/
https://www.ncbi.nlm.nih.gov/pubmed/29776921
http://dx.doi.org/10.1136/bmjopen-2018-021512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961565/
https://www.ncbi.nlm.nih.gov/pubmed/29776921
http://dx.doi.org/10.1136/bmjopen-2018-021512

Ejemplares similares